Amiodarone Cases, Nos. A161023, A161762, 2022 Cal. App. LEXIS 912 (Ct. App. Nov. 3, 2022)
The federal Food and Drug Act preempts plaintiffs' state law claims based on the drug manufacturers' alleged failure to assure that patients received Medication Guides (which are part of the FDA-approved drug label). The FDA leaves enforcement of regulations dealing with drug labels in the FDA's hands, barring private suits to enforce FDA regulations. Under California law, drug manufacturers have… Read More